This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Assault by unspecified means
VWXY20_ASSAU_UNSPE_MEANS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
791 |
4. Check minimum number of eventsNone |
791 |
5. Include endpointsNone |
791 |
6. Filter based on genotype QC (FinnGen only) |
791 |
Control definitions (FinnGen only)
- Control exclude
- VWXY20_ASSAULT
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- X85-Y09
Assault by unspecified means
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 791 | 329 | 462 |
| Unadjusted period prevalence (%) | 0.17 | 0.11 | 0.20 |
| Median age at first event (years) | 38.60 | 37.30 | 39.53 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 711
- Matched controls
- 7109
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Y09
ICD-10 Finland
Assault by unspecified means
+∞
323.0
707
*
T74.1
ICD-10 Finland
Physical abuse
60.7
176.5
205
47
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
12.4
113.8
223
253
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
1214.3
109.5
104
*
S06.0
ICD-10 Finland
Concussion
9.3
105.7
248
387
T36
ICD-10 Finland
Poisoning by systemic antibiotics
11.3
80.5
161
179
N05AH04
ATC
quetiapine; oral
5.5
77.9
284
766
AA1AD
NOMESCO Finland
CT of head and brain
5.7
76.1
263
663
S01.0
ICD-10 Finland
Open wound of scalp
9.6
75.6
166
218
Y07
ICD-10 Finland
Other maltreatment
+∞
73.2
69
*
X59
ICD-10 Finland
Exposure to unspecified factor
4.9
70.9
290
871
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
12.3
70.0
133
131
Y04.0
ICD-10 Finland
Assault by bodily force by spouse or partner
+∞
58.1
55
*
N07BB01
ATC
disulfiram; oral
8.8
57.1
130
176
Y04.8
ICD-10 Finland
Assault by bodily force by other known person
+∞
57.1
54
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
4.0
55.6
291
1055
F10.09
ICD-10 Finland
Alcohol intoxication UNS
16.1
55.0
91
64
N05BA04
ATC
oxazepam; oral
4.0
53.5
270
940
F32.9
ICD-10 Finland
Depressive episode, unspecified
4.6
50.7
207
586
P15
ICPC
Chronic alcohol abuse
10.9
49.8
99
104
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
14.0
49.6
87
70
N06AX11
ATC
mirtazapine; oral
3.5
49.6
322
1363
S02.20
ICD-10 Finland
Fracture of nasal bones, closed
15.6
49.0
82
59
F10.25
ICD-10 Finland
Alcohol dependence continuous use
18.4
48.5
76
46
NA1AD
NOMESCO Finland
Cervical spine CT examination
10.1
47.3
98
111
N05BA01
ATC
diazepam; systemic, rectal
4.8
45.1
171
443
S00.1
ICD-10 Finland
Contusion of eyelid and periocular area
15.4
41.9
70
50
S02.30
ICD-10 Finland
Fracture of orbital floor, closed
47.7
40.6
49
11
X58
ICD-10 Finland
Exposure to other specified factors
3.6
38.4
204
708
N02AX02
ATC
tramadol; systemic, rectal
2.9
37.6
326
1600
N05AH03
ATC
olanzapine; systemic
5.3
37.5
123
268
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
13.0
34.6
62
52
B18.2
ICD-10 Finland
Chronic viral hepatitis C
13.2
34.4
61
50
F10.20
ICD-10 Finland
Alcohol dependence currently independent
11.2
33.9
65
63
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.9
33.6
155
472
S22.3
ICD-10 Finland
Fracture of rib
6.0
32.8
96
181
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
3.8
32.4
154
480
Y04.2
ICD-10 Finland
Assault by bodily force by friend
331.2
32.1
32
*
N06AX16
ATC
venlafaxine; oral
3.4
31.1
174
617
N02BE01
ATC
paracetamol; systemic, rectal
3.2
30.9
611
4672
F10.24
ICD-10 Finland
Alcohol depence active use
11.8
30.6
57
52
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.7
30.4
111
269
N05CF01
ATC
zopiclone; oral
2.8
30.3
240
1079
ZXD05
NOMESCO Finland
Urgent procedure
2.7
30.1
275
1345
N06AB04
ATC
citalopram; systemic
3.1
30.0
197
780
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
29.4
306
1610
N05CD07
ATC
temazepam; oral
4.7
28.7
103
245
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
4.3
28.6
114
301
P19
ICPC
Drug abuse
13.8
28.3
49
38
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
10.4
28.2
56
58
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
20.2
28.2
42
22
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
4.0
28.0
122
349
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
4.2
27.8
114
309
S02.40
ICD-10 Finland
Fracture of malar and maxillary bones, closed
22.2
27.7
40
19
N03AX16
ATC
pregabalin; oral
3.0
27.6
194
797
N06AB03
ATC
fluoxetine; oral
3.7
27.3
134
424
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.6
27.0
82
161
N06AB10
ATC
escitalopram; oral
2.7
27.0
223
1016
N05AA02
ATC
levomepromazine; systemic
6.3
26.6
73
126
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
17.1
26.6
42
26
T90.5
ICD-10 Finland
Sequelae of intracranial injury
15.1
26.5
44
31
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.7
26.5
128
400
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.4
26.4
365
2190
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
11.9
26.0
48
43
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
25.2
25.9
36
15
WX110
NOMESCO Finland
Local anesthesy
2.6
25.6
558
4176
N03AE01
ATC
clonazepam; systemic
5.3
25.6
81
167
N03AG01
ATC
valproic acid; systemic, rectal
4.8
25.5
90
209
Z72.2
ICD-10 Finland
Drug use
21.6
25.4
37
18
W19
ICD-10 Finland
Unspecified fall
3.9
24.3
107
307
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
12.6
24.1
43
36
EB1AA
NOMESCO Finland
Tooth X-ray examination
2.3
24.0
447
3038
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
4.0
24.0
103
289
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
13.5
23.7
41
32
S00.0
ICD-10 Finland
Superficial injury of scalp
10.6
23.6
46
46
AA3AA
NOMESCO Finland
Facial bones X-ray examination
48.5
23.5
28
6
C07AA05
ATC
propranolol; systemic
2.7
23.4
186
816
SPAT1254
SPAT
Administration of medicine
3.4
23.3
127
433
EBA00
NOMESCO Finland
Extraction of tooth
2.3
23.1
306
1762
AA3AD
NOMESCO Finland
CT of face
26.9
22.8
31
12
N05AX08
ATC
risperidone; systemic
4.1
22.6
93
251
P01
ICPC
Feeling anxious/nervous/tense
3.0
22.5
147
569
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
7.0
22.2
56
86
A02BC02
ATC
pantoprazole; systemic
2.2
22.0
424
2873
SPAT1263
SPAT
Sampling
2.2
22.0
321
1921
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
5.8
21.7
63
117
P16
ICPC
Acute alcohol abuse
9.0
21.7
46
54
F41.09
ICD-10 Finland
UNS Panic Syndrome
5.5
21.5
65
127
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
19.7
21.4
32
17
N03AX12
ATC
gabapentin; oral
3.1
21.4
132
489
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
10.3
21.3
42
43
Z2446
NOMESCO Finland
Social worker
4.0
21.3
90
249
S00.8
ICD-10 Finland
Superficial injury of other parts of head
12.9
21.1
37
30
Y00.9
ICD-10 Finland
Assault by blunt object by unknown person
+∞
20.9
20
*
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
7.3
20.6
50
73
AA1XD
NOMESCO Finland
Other special CT of head and brain
43.0
20.6
25
6
T00.9
ICD-10 Finland
Multiple superficial injuries, unspecified
20.8
20.5
30
15
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.2
20.3
286
1666
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
4.7
20.2
71
164
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
15.0
20.0
33
23
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
2.1
19.9
401
2719
S18
ICPC
Laceration/cut
2.2
19.7
277
1608
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
22.4
19.6
28
13
P74
ICPC
Anxiety disorder/anxiety state
4.8
19.4
66
147
W22
ICD-10 Finland
Striking against or struck by other object(s)
3.5
19.3
95
298
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
4.0
19.0
78
210
N06AB06
ATC
sertraline; oral
3.0
18.8
116
429
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
21.5
18.7
27
13
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
14.7
18.7
31
22
SPAT1260
SPAT
Consultation of another employee
2.7
18.7
139
579
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
4.0
18.7
78
213
CAC10
NOMESCO Finland
Reconstruction of orbital wall using bone graft or plate
194.9
18.6
19
*
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
15.6
18.6
30
20
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
10.5
18.6
36
36
N06AX21
ATC
duloxetine; oral
3.2
18.5
107
376
Y34
ICD-10 Finland
Unspecified event, undetermined intent
20.0
18.3
27
14
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
4.6
18.2
65
153
ND1BA
NOMESCO Finland
Wrist extensive X-ray examination
9.5
18.1
37
41
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
5.8
18.0
52
96
SPAT1301
SPAT
No procedures
2.2
18.0
226
1236
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
18.0
206
1079
S20.2
ICD-10 Finland
Contusion of thorax
4.7
17.8
62
142
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.8
17.6
77
219
P18
ICPC
Medication abuse
17.5
17.5
27
16
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.3
17.5
201
1053
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
10.8
17.3
33
32
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
6.6
17.1
44
70
SPAT1153
SPAT
Removal of sutures
2.2
17.1
202
1067
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
3.5
17.0
83
258
N05BA12
ATC
alprazolam; oral
3.1
17.0
100
356
NC2AA
NOMESCO Finland
Forearm X-ray examination
12.5
17.0
30
25
SPAT1275
SPAT
Drug rehabilitation and replacement therapy of opioid-dependent person
22.5
17.0
24
11
S06.2
ICD-10 Finland
Diffuse brain injury
14.5
16.9
28
20
N05BA02
ATC
chlordiazepoxide; systemic
7.7
16.9
39
53
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.7
16.8
122
498
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.1
16.8
233
1319
F60.9
ICD-10 Finland
Personality disorder, unspecified
8.0
16.8
38
50
X99.9
ICD-10 Finland
Assault by sharp object by unknown person
+∞
16.7
16
*
M54.5
ICD-10 Finland
Low back pain
2.1
16.6
257
1526
R51.80
ICD-10 Finland
Headache
2.5
16.6
147
670
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
7.1
16.4
40
59
M79.6
ICD-10 Finland
Pain in limb
2.1
16.4
257
1534
S01.9
ICD-10 Finland
Open wound of head, part unspecified
10.8
16.3
31
30
Z72.1
ICD-10 Finland
Alcohol use
9.6
16.3
33
36
TQW40
NOMESCO Finland
Remowal of suture of skin
3.8
16.3
71
201
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
16.2
235
1355
WX290
NOMESCO Finland
Other blockade of nerve
1.9
16.1
407
2907
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
14.9
15.9
26
18
F11.24
ICD-10 Finland
Addiction-induced dependence caused by opiates active addiction
34.2
15.8
20
6
F61.0
ICD-10 Finland
Mixed personality disorders
6.9
15.8
39
59
N03AX09
ATC
lamotrigine; oral
3.9
15.7
66
181
L03
ICPC
Low back symptom/complaint
2.2
15.7
186
980
P29
ICPC
Psychological sympt/compl other
3.3
15.5
80
260
K02.1
ICD-10 Finland
Caries of dentine
1.9
15.5
476
3627
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.5
15.5
131
584
NB6AA
NOMESCO Finland
Humerus X-ray examination
10.7
15.3
29
28
X78
ICD-10 Finland
Intentional self-harm by sharp object
16.5
15.3
24
15
N05AB01
ATC
dixyrazine; systemic
10.1
15.3
30
31
J01DB01
ATC
cefalexin; oral
2.2
15.2
589
4899
SPAT1272
SPAT
Drug screening
18.2
15.2
23
13
SAA01
NOMESCO Finland
Simple examination of mouth
2.0
15.2
549
4436
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.0
15.1
251
1517
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
8.8
15.1
32
38
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
4.0
15.0
61
163
N05CF02
ATC
zolpidem; oral
2.4
14.9
142
673
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.7
14.8
107
434
N06AB05
ATC
paroxetine; oral
3.4
14.8
73
229
F51.0
ICD-10 Finland
Nonorganic insomnia
2.5
14.7
129
584
P03
ICPC
Feeling depressed
2.7
14.7
110
456
N06AA12
ATC
doxepin; systemic
4.9
14.7
48
103
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
3.5
14.7
70
214
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.9
14.6
96
367
DHD10
NOMESCO Finland
Closed reduction of fracture of nose
11.2
14.6
27
25
S93.4
ICD-10 Finland
Sprain and strain of ankle
2.5
14.5
122
537
S00.7
ICD-10 Finland
Multiple superficial injuries of head
36.9
14.5
18
5
QAB00
NOMESCO Finland
Suture of skin of head or neck
8.1
14.5
32
41
S62.3
ICD-10 Finland
Fracture of other metacarpal bone
4.6
14.5
50
114
K04.0
ICD-10 Finland
Pulpitis
2.6
14.4
116
499
SPAT1310
SPAT
Counselling related to known health issue
2.0
14.4
235
1409
N02AJ06
ATC
codeine and paracetamol; systemic
1.9
14.3
281
1805
N05AX12
ATC
aripiprazole; systemic
3.6
14.3
65
191
XF400
NOMESCO Finland
ECG with 12 standard connections
2.6
14.1
109
460
W00
ICD-10 Finland
Fall on same level involving ice and snow
2.9
14.1
92
350
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.4
14.0
125
570
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
16.2
14.0
22
14
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.5
14.0
120
538
K92.0
ICD-10 Finland
Haematemesis
6.9
13.9
34
51
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
20.5
13.8
20
10
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
13.8
173
925
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
13.9
13.8
23
17
V03AA01
ATC
NA
8.2
13.7
30
38
D11
ICPC
Diarrhoea
2.5
13.7
113
496
F10.03
ICD-10 Finland
Alcohol-related acute intoxication with delirium
76.6
13.6
15
*
N05BE01
ATC
buspirone; oral
5.3
13.6
41
81
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
2.8
13.5
93
365
S01.40
ICD-10 Finland
Open wound on the cheek
16.6
13.5
21
13
F43.1
ICD-10 Finland
Post-traumatic stress disorder
4.8
13.5
45
99
SPAT1211
SPAT
Application of soft bandage
3.1
13.5
77
269
N06AX03
ATC
mianserin; oral
4.7
13.5
46
104
Z09.4
ICD-10 Finland
Follow-up examination after treatment of fracture
4.5
13.4
47
109
ND1AA
NOMESCO Finland
Wrist X-ray examination
3.9
13.2
55
150
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
8.1
13.2
29
37
F31.8
ICD-10 Finland
Other bipolar affective disorders
6.4
13.2
34
55
F29
ICD-10 Finland
Unspecified nonorganic psychosis
3.4
13.1
64
200
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
4.7
13.1
44
98
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
4.6
13.0
45
103
SPAT1249
SPAT
Treatment-related counselling outside office
1.9
13.0
276
1805
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.8
12.9
89
348
F41.1
ICD-10 Finland
Generalized anxiety disorder
3.4
12.9
64
202
S01.51
ICD-10 Finland
Open wound on lip
6.5
12.9
33
53
N06AX05
ATC
trazodone; oral
5.8
12.9
36
65
SPAT1240
SPAT
Therapeutic discussion
2.4
12.8
120
561
NHJ10
NOMESCO Finland
Internal fixation of fracture of ankle using wire, rod, cerclage or pin
4.2
12.7
48
120
WX204
NOMESCO Finland
Axillary plexus blockaced
4.8
12.7
42
92
S06.3
ICD-10 Finland
Focal brain injury
12.6
12.7
22
18
K05.31
ICD-10 Finland
Periodontitis pronounced
3.0
12.7
76
273
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
3.5
12.6
60
183
C03CA01
ATC
furosemide; systemic
2.6
12.6
100
425
S02.80
ICD-10 Finland
Fractures of other skull and facial bones, closed
71.2
12.6
14
*
N07BA03
ATC
varenicline; oral
3.2
12.6
68
229
Y00.8
ICD-10 Finland
Assault by blunt object by other known person
+∞
12.5
12
*
Y00.0
ICD-10 Finland
Assault by blunt object by spouse or partner
+∞
12.5
12
*
Y08.9
ICD-10 Finland
Assault by other specified means by unknown person
+∞
12.5
12
*
EBA15
NOMESCO Finland
Extraction of large number of teeth
4.8
12.5
41
89
S82.6
ICD-10 Finland
Fracture of lateral malleolus
3.5
12.5
58
174
R74
ICPC
Upper respiratory infection acute
1.9
12.4
257
1662
N06BA04
ATC
methylphenidate; oral
4.1
12.4
48
123
SPAT1312
SPAT
General health counselling
1.9
12.4
237
1491
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.1
12.4
167
918
F90.0
ICD-10 Finland
Disturbance of activity and attention
3.7
12.4
54
154
S00.9
ICD-10 Finland
Superficial injury of head, part unspecified
14.7
12.3
20
14
S01.7
ICD-10 Finland
Multiple open wounds of head
14.7
12.3
20
14
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
3.8
12.3
52
144
S05.1
ICD-10 Finland
Contusion of eyeball and orbital tissues
5.4
12.3
36
69
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.0
12.2
72
257
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.6
12.2
56
166
-1
NOMESCO Finland
NA
1.8
12.2
286
1924
ZXE20
NOMESCO Finland
More than three and less than five hours
2.7
12.1
89
364
N05AF03
ATC
chlorprothixene; systemic
4.7
12.1
41
92
SGA01
NOMESCO Finland
Tooth opening as first aid
2.1
12.1
154
824
SPAT1227
SPAT
Substance abuse rehabilitation
11.3
12.1
22
20
S09.9
ICD-10 Finland
Unspecified injury of head
9.5
12.1
24
26
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
3.3
12.0
61
196
R07.4
ICD-10 Finland
Chest pain, unspecified
2.0
12.0
166
923
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.2
12.0
132
666
S52.5
ICD-10 Finland
Fracture of lower end of radius
3.1
11.9
67
230
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.2
11.9
62
203
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
4.2
11.9
45
113
M54.4
ICD-10 Finland
Lumbago with sciatica
2.3
11.9
121
589
R41.0
ICD-10 Finland
Disorientation, unspecified
9.2
11.8
24
27
EBA05
NOMESCO Finland
Complicated extraction of tooth
2.1
11.8
156
849
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
2.3
11.8
111
520
SPAT1283
SPAT
Restricted health certificate
1.9
11.7
194
1153
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.8
11.7
49
135
S62.6
ICD-10 Finland
Fracture of other finger
3.3
11.7
59
189
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
12.8
11.7
20
16
EDC38
NOMESCO Finland
Open reduction and fixation of fracture of body of mandible
30.6
11.7
15
5
Z25
ICPC
Assault/harmful event problem
11.4
11.6
21
19
ZY010
NOMESCO Finland
Hospital outpatient
3.2
11.6
61
202
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
9.5
11.6
23
25
A46
ICD-10 Finland
Erysipelas
2.6
11.5
86
356
X99.0
ICD-10 Finland
Assault by sharp object by spouse or partner
+∞
11.5
11
*
NE1AA
NOMESCO Finland
Pelvis X-ray examination
4.1
11.5
44
112
ZXA05
NOMESCO Finland
Left side
2.1
11.5
144
766
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.6
11.5
85
350
S00.3
ICD-10 Finland
Superficial injury of nose
12.1
11.4
20
17
T51.0
ICD-10 Finland
Toxic effect: Ethanol
10.8
11.3
21
20
F05.9
ICD-10 Finland
Delirium, unspecified
10.8
11.3
21
20
F41.0
ICD-10 Finland
Panic disorder [episodic paroxysmal anxiety]
4.9
11.3
36
76
SPAT1307
SPAT
Psychosocial counselling and guidance
2.7
11.3
83
337
P17
ICPC
Tobacco abuse
7.0
11.2
27
40
F41.00
ICD-10 Finland
Moderate panic disorder
5.5
11.2
32
60
NDU20
NOMESCO Finland
Removal of internal fixation device from wrist or hand
5.5
11.2
32
60
S01.2
ICD-10 Finland
Open wound of nose
8.2
11.2
24
30
M03BC01
ATC
orphenadrine (citrate); systemic
1.9
11.1
185
1100
F12.1
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, harmful use
11.4
11.1
20
18
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
11.1
138
733
F10.01
ICD-10 Finland
Alcohol-related acute intoxication with permanent or other somatic damage
15.8
10.9
17
11
S06.9
ICD-10 Finland
Intracranial injury, unspecified
15.8
10.9
17
11
SPAT1265
SPAT
Breathalyser
7.4
10.8
25
35
ZY000
NOMESCO Finland
Hospital inpatient
5.8
10.8
30
54
A01
ICPC
Pain general/multiple sites
3.1
10.8
58
195
LCH11
NOMESCO Finland
Pharmacologic abortion
3.9
10.8
43
114
K08.3
ICD-10 Finland
Retained dental root
3.0
10.6
61
214
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.1
10.5
59
202
Z04.3
ICD-10 Finland
Examination and observation following other accident
6.0
10.5
28
48
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
10.5
141
768
N06AX12
ATC
bupropion; oral
2.6
10.5
76
309
P01AB01
ATC
metronidazole; oral, rectal
1.8
10.5
249
1665
Y00.2
ICD-10 Finland
Assault by blunt object by friend
+∞
10.4
10
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
10.4
163
943
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
16.3
10.4
16
10
Z72.8
ICD-10 Finland
Other problems related to lifestyle
16.3
10.4
16
10
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.3
10.4
99
463
JN5BD
NOMESCO Finland
Head and body CT examination for trauma
9.8
10.3
20
21
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
10.3
313
2247
Z08
ICPC
Social welfare problem
7.6
10.2
23
31
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
13.4
10.2
17
13
Z3226
NOMESCO Finland
Physiotherapist
2.1
10.2
126
666
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.8
10.1
230
1513
WX002
NOMESCO Finland
Sedation and analgesia
2.2
10.1
113
569
Z00.0
ICD-10 Finland
General medical examination
2.1
10.1
127
674
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
2.7
10.1
70
277
D10
ICPC
Vomiting
2.7
10.0
71
285
A03
ICPC
Fever
2.0
10.0
152
869
A06AD11
ATC
lactulose; oral
2.7
10.0
69
270
ZXA00
NOMESCO Finland
Right side
2.0
10.0
148
836
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
3.5
10.0
46
138
P99
ICPC
Psychological disorders other
4.0
10.0
39
102
S41.1
ICD-10 Finland
Open wound of upper arm
17.0
9.9
15
9
N06AX26
ATC
vortioxetine; oral
2.9
9.9
61
224
SPAT1247
SPAT
Outpatient detoxication and monitoring
12.4
9.9
17
14
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.7
9.9
404
3138
S42.0
ICD-10 Finland
Fracture of clavicle
4.3
9.9
36
88
R03AC02
ATC
salbutamol; inhalant
1.7
9.8
355
2666
SPAT1281
SPAT
Other administrative function
2.7
9.8
66
257
WX402
NOMESCO Finland
General anaesthesia
2.1
9.8
125
666
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.8
9.8
193
1209
K04.7
ICD-10 Finland
Periapical abscess without sinus
3.0
9.7
56
197
S61.8
ICD-10 Finland
Open wound of other parts of wrist and hand
4.9
9.7
31
66
L08
ICPC
Shoulder symptom/complaint
2.1
9.7
117
610
NF1AA
NOMESCO Finland
Hip X-ray examination
3.6
9.7
43
125
N06AA09
ATC
amitriptyline; systemic
2.8
9.7
62
235
S21.1
ICD-10 Finland
Open wound of front wall of thorax
55.8
9.7
11
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.5
9.7
74
310
WX892
NOMESCO Finland
Monitored bed care
2.9
9.6
59
214
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
3.8
9.6
39
106
Z3231
NOMESCO Finland
Registered nurse
1.8
9.5
177
1084
Z2445
NOMESCO Finland
Psychologist
3.4
9.5
45
138
P06
ICPC
Sleep disturbance
2.4
9.5
82
366
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
4.4
9.5
33
77
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.6
9.5
70
287
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
4.7
9.5
31
68
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.3
9.5
87
402
Y90.8
ICD-10 Finland
Blood alcohol level of 240 mg/100 ml or more
101.3
9.4
10
*
K10.3
ICD-10 Finland
Alveolitis of jaws
3.1
9.4
53
182
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.5
9.4
75
320
Y08.8
ICD-10 Finland
Assault by other specified means by other known person
+∞
9.4
9
*
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
12.6
9.4
16
13
A29
ICPC
General symptom/complaint other
2.6
9.4
70
290
IGY99
NOMESCO Finland
Other psychiatric treatment contact
4.8
9.3
30
65
JN3AD
NOMESCO Finland
Abdominal CT examination
3.0
9.3
54
192
SPAT1291
SPAT
Other function in accordance with NCSP classification
7.4
9.3
21
29
A11
ICPC
Chest pain NOS
3.2
9.3
48
158
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
3.5
9.3
42
125
R4110
NOMESCO Finland
Physiotherapy
1.9
9.2
162
974
F32
ICD-10 Finland
Depressive episode
2.7
9.2
61
235
Y94.8
ICD-10 Finland
Other leisure activity accident
4.0
9.2
35
90
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
3.9
9.1
36
95
Z71.4
ICD-10 Finland
Alcohol abuse counselling and surveillance
11.7
9.1
16
14
R06.0
ICD-10 Finland
Dyspnoea
2.0
9.1
131
734
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
9.2
9.1
18
20
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.4
9.1
76
334
XX3DW
NOMESCO Finland
Time consuming IT work
2.7
9.1
61
238
EEC35
NOMESCO Finland
Reduction and osteosynthesis of zygomaticomaxillary fracture
37.2
9.0
11
*
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
6.6
9.0
22
34
S92.3
ICD-10 Finland
Fracture of metatarsal bone
3.9
8.9
36
97
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
2.2
8.9
92
445
W10
ICD-10 Finland
Fall on and from stairs and steps
3.3
8.9
44
140
SPAT1234
SPAT
Support of social functional capacity
3.7
8.9
37
103
NG4AA
NOMESCO Finland
Lower leg X-ray examination
4.1
8.9
33
83
A28
ICPC
Limited function/disability NOS
2.8
8.8
57
218
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.6
8.8
38
109
KMAK
NOMESCO Finland
NA
1.6
8.8
396
3118
L84
ICPC
Back syndrome without radiat pain
3.5
8.7
39
115
T92.2
ICD-10 Finland
Sequelae of fracture at wrist and hand level
14.3
8.7
14
10
R4120
NOMESCO Finland
Occupational therapy
2.9
8.7
52
189
EEC30
NOMESCO Finland
Reduction of zygomaticomaxillary fracture
50.6
8.7
10
*
WX872
NOMESCO Finland
Intensive care
3.8
8.6
35
95
R11
ICD-10 Finland
Nausea and vomiting
2.6
8.6
62
251
Z01.9
ICD-10 Finland
Special examination, unspecified
3.6
8.6
38
111
S02.00
ICD-10 Finland
Fracture of the upper part of the head closed
16.5
8.6
13
8
S05.9
ICD-10 Finland
Injury of eye and orbit, unspecified
9.1
8.6
17
19
S82.8
ICD-10 Finland
Fractures of other parts of lower leg
3.7
8.6
36
101
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
3.7
8.6
36
101
ZA1.0
ICD-10 Finland
Shoulder region
6.5
8.5
21
33
M01AE01
ATC
ibuprofen; systemic, rectal
2.1
8.5
647
5888
QCB00
NOMESCO Finland
Suture of skin of upper limb
5.5
8.5
24
45
L12
ICPC
Hand/finger symptom/complaint
2.0
8.5
108
574
R02
ICPC
Shortness of breath/dyspnoea
2.4
8.5
75
338
F10.05
ICD-10 Finland
Alcohol-related acute intoxication with coma
27.9
8.5
11
*
SAA02
NOMESCO Finland
Basic examination of mouth
1.6
8.5
488
4073
Z71.8
ICD-10 Finland
Other specified counselling
1.8
8.4
180
1149
L17
ICPC
Foot/toe symptom/complaint
1.9
8.4
146
871
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
3.1
8.4
44
147
X99.2
ICD-10 Finland
Assault by sharp object by friend
+∞
8.3
8
*
J01FF01
ATC
clindamycin; systemic
1.8
8.3
179
1142
N05AD03
ATC
melperone; systemic
8.7
8.3
17
20
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
9.6
8.3
16
17
K85.2
ICD-10 Finland
Alcohol-induced acute pancreatitis
9.6
8.3
16
17
P76
ICPC
Depressive disorder
2.4
8.3
69
303
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
3.1
8.3
45
154
SPAT1104
SPAT
Monitoring of emergency patient
3.1
8.3
45
154
N05AN01
ATC
lithium; oral
4.1
8.2
31
79
Z04.0
ICD-10 Finland
Blood-alcohol and blood-drug test
14.7
8.2
13
9
S80.0
ICD-10 Finland
Contusion of knee
2.6
8.2
59
239
F40.1
ICD-10 Finland
Social phobias
3.6
8.2
36
105
S51.9
ICD-10 Finland
Open wound of forearm, part unspecified
7.7
8.2
18
24
R29
ICPC
Respiratory symptom/complaint other
2.7
8.2
55
213
S61.9
ICD-10 Finland
Open wound of wrist and hand, part unspecified
3.5
8.1
37
111
S92.0
ICD-10 Finland
Fracture of calcaneus
8.3
8.1
17
21
K04.1
ICD-10 Finland
Necrosis of pulp
2.1
8.1
89
445
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.6
8.1
61
252
X84
ICD-10 Finland
Intentional self-harm by unspecified means
33.8
8.1
10
*
F11.20
ICD-10 Finland
Addiction-induced dependence caused by opiates currently independent
17.4
8.1
12
7
N80
ICPC
Head injury other
6.4
8.1
20
32
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
10.2
8.1
15
15
-34
ICPC
Blood test
4.1
8.0
30
76
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.6
8.0
234
1631
ZYC01
NOMESCO Finland
Remote contact by phone
3.1
8.0
42
140
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.4
8.0
65
283
K04.08
ICD-10 Finland
Other specified pulpit
2.3
8.0
70
317
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
8.0
136
808
N02AA05
ATC
oxycodone; systemic
2.4
7.9
67
297
S27.1
ICD-10 Finland
Traumatic haemothorax
13.2
7.9
13
10
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.4
7.9
66
291
F99
ICD-10 Finland
Mental disorder, not otherwise specified
4.2
7.9
28
68
WZA90
NOMESCO Finland
Other doctors statement
1.7
7.9
175
1130
W52
ICD-10 Finland
Crushed, pushed or stepped on by crowd or human stampede
4.0
7.8
30
78
ZXE00
NOMESCO Finland
One hour or less
1.6
7.8
246
1749
S72.1
ICD-10 Finland
Pertrochanteric fracture
11.0
7.8
14
13
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
7.8
363
2846
F39
ICD-10 Finland
Unspecified mood [affective] disorder
4.3
7.8
27
64
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
4.2
7.8
28
69
S42.2
ICD-10 Finland
Fracture of upper end of humerus
4.2
7.8
28
69
TPH07
NOMESCO Finland
Cathetrisation of artery
2.5
7.8
57
235
TNX99
NOMESCO Finland
Other orthopaedic minor procedure
3.9
7.7
30
79
F11.21
ICD-10 Finland
Addiction-indiced dependence caused by opiates currently independent but staying in controlling environment
45.5
7.7
9
*
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.0
7.7
95
500
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
3.4
7.7
36
111
M25.5
ICD-10 Finland
Pain in joint
1.7
7.7
179
1171
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
8.2
7.6
16
20
Z00.8
ICD-10 Finland
Other general examinations
2.5
7.6
59
250
G40.9
ICD-10 Finland
Epilepsy, unspecified
3.5
7.6
34
101
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
12.0
7.6
13
11
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
4.4
7.6
26
61
S02.69
ICD-10 Finland
Fracture of the lower jaw UNS
25.3
7.6
10
*
S02.60
ICD-10 Finland
Fracture of mandible, closed
25.3
7.6
10
*
S01.3
ICD-10 Finland
Open wound of ear
6.3
7.6
19
31
S01.8
ICD-10 Finland
Open wound of other parts of head
5.5
7.6
21
39
F43.0
ICD-10 Finland
Acute stress reaction
2.8
7.6
48
181
Z04.4
ICD-10 Finland
Examination and observation following alleged rape and seduction
10.2
7.6
14
14
R07.3
ICD-10 Finland
Other chest pain
2.5
7.5
58
244
R42
ICD-10 Finland
Dizziness and giddiness
2.0
7.5
106
585
L03.9
ICD-10 Finland
Cellulitis, unspecified
5.1
7.5
22
44
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
3.7
7.5
31
87
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
4.1
7.4
27
67
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
3.4
7.4
34
103
L01
ICPC
Neck symptom/complaint
2.1
7.4
89
463
Z64.0
ICD-10 Finland
Problems related to unwanted pregnancy
3.9
7.4
29
77
R52.2
ICD-10 Finland
Other chronic pain
3.9
7.4
29
77
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
5.4
7.4
21
40
TND32
NOMESCO Finland
Custom moulded splint, wrist or hand
7.8
7.4
16
21
EFB40
NOMESCO Finland
Removal of internal or external fixation device from facial bones
13.5
7.4
12
9
Z86.4
ICD-10 Finland
Personal history of psychoactive substance abuse
13.5
7.4
12
9
EBA30
NOMESCO Finland
Excision of root of tooth
2.8
7.4
44
161
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.4
7.4
60
261
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.7
7.4
156
992
Z72.0
ICD-10 Finland
Tobacco use
3.8
7.3
29
78
SPAT1252
SPAT
Overall medication plan or its review
3.3
7.3
35
110
X85.9
ICD-10 Finland
Assault by drugs, medicaments and biological substances by unknown person
+∞
7.3
7
*
X99.8
ICD-10 Finland
Assault by sharp object by other known person
+∞
7.3
7
*
T40.6
ICD-10 Finland
Poisoning: Other and unspecified narcotics
+∞
7.3
7
*
F19.00
ICD-10 Finland
Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated
15.9
7.2
11
7
J01DA01
ATC
[U] cefalexin; systemic
1.5
7.2
407
3310
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.6
7.2
50
200
R55
ICD-10 Finland
Syncope and collapse
2.4
7.2
59
258
F11.29
ICD-10 Finland
Addiction caused by opiates UNS
20.3
7.1
10
5
S02.70
ICD-10 Finland
Multiple fractures involving skull and facial bones, closed
20.3
7.1
10
5
S51.8
ICD-10 Finland
Open wound of other parts of forearm
6.7
7.1
17
26
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
4.6
7.1
23
51
S02
ICPC
Pruritus
3.3
7.1
34
107
S06.6
ICD-10 Finland
Traumatic subarachnoid haemorrhage
12.2
7.1
12
10
F15.5
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
12.2
7.1
12
10
R05
ICPC
Cough
1.8
7.1
138
850
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
3.8
7.0
28
76
OAB48
SPAT
NA
0.3
7.0
20
553
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
5.0
7.0
21
43
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
5.0
7.0
21
43
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
4.5
7.0
23
52
-50
ICPC
Medication/prescr/renewal
3.5
7.0
31
92
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.1
7.0
75
373
S50.1
ICD-10 Finland
Contusion of other and unspecified parts of forearm
6.4
7.0
17
27
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.6
7.0
48
190
IGY02
NOMESCO Finland
Psychiatric monitoring contact
3.6
7.0
29
82
OAB43
SPAT
NA
0.5
7.0
68
1199
S30.1
ICD-10 Finland
Contusion of abdominal wall
5.9
6.9
18
31
S31.1
ICD-10 Finland
Open wound of abdominal wall
13.9
6.9
11
8
NFJ54
NOMESCO Finland
Internal fixation of fracture of upper femur with intramedullary nail
13.9
6.9
11
8
K86.08
ICD-10 Finland
Alcohol-induced chronic pancreatitis
13.9
6.9
11
8
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
6.9
211
1480
N05AB03
ATC
perphenazine; systemic, rectal
3.3
6.9
32
99
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
6.8
357
2842
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
11.1
6.8
12
11
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
9.4
6.8
13
14
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
6.2
6.8
17
28
T79.3
ICD-10 Finland
Post-traumatic wound infection, not elsewhere classified
5.7
6.8
18
32
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.8
6.8
43
161
Y87.1
ICD-10 Finland
Sequelae of assault
40.4
6.8
8
*
F10.3
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Withdrawal state
16.9
6.8
10
6
LCH00
NOMESCO Finland
Vacuum aspiration of products of conception from uterus
3.8
6.7
27
74
N06AB08
ATC
fluvoxamine; oral
3.9
6.7
26
69
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.0
6.7
38
132
G56.2
ICD-10 Finland
Lesion of ulnar nerve
3.4
6.7
30
90
ZXD35
NOMESCO Finland
Usual procedure
3.4
6.7
30
90
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.5
6.7
419
3460
L86
ICPC
Back syndrome with radiating pain
2.8
6.7
40
147
F10.41
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol with seizures
22.8
6.7
9
*
ZZA00
NOMESCO Finland
Split skin graft
4.3
6.7
23
55
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
5.6
6.6
18
33
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
2.3
6.6
61
283
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.5
6.6
49
201
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
6.6
155
1012
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.5
6.6
263
1965
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
4.4
6.6
22
51
A04
ICPC
Weakness/tiredness general
2.0
6.6
82
431
TNX34
NOMESCO Finland
Major custom molded cast, unspecified region
4.9
6.6
20
42
R52.9
ICD-10 Finland
Pain, unspecified
2.3
6.6
60
276
W17
ICD-10 Finland
Other fall from one level to another
2.7
6.5
42
160
F34.1
ICD-10 Finland
Dysthymia
3.0
6.5
37
129
S82.3
ICD-10 Finland
Fracture of lower end of tibia
3.9
6.5
25
66
S22.4
ICD-10 Finland
Multiple fractures of ribs
4.6
6.5
21
47
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.8
6.5
39
144
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.2
6.5
62
291
NDJ64
NOMESCO Finland
Internal fixation of fracture of wrist or hand wire, rod, cerclage or pin
4.3
6.5
22
52
S99.9
ICD-10 Finland
Unspecified injury of ankle and foot
3.6
6.5
27
77
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.2
6.5
64
305
Z29
ICPC
Social problem NOS
4.1
6.4
23
57
F19.09
ICD-10 Finland
Intoxication caused by several drugs in combination and by other psychoactive substances UNS
70.5
6.4
7
*
F10
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol
70.5
6.4
7
*
O35.5
ICD-10 Finland
Maternal care for (suspected) damage to fetus by drugs
70.5
6.4
7
*
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
6.4
81
429
T40.9
ICD-10 Finland
Poisoning: Other and unspecified psychodysleptics [hallucinogens]
14.5
6.4
10
7
R21
ICPC
Throat symptom/complaint
1.6
6.4
170
1145
A63.0
ICD-10 Finland
Anogenital (venereal) warts
2.5
6.4
46
189
N30.0
ICD-10 Finland
Acute cystitis
2.1
6.4
71
359
F60.2
ICD-10 Finland
Dissocial personality disorder
8.3
6.4
13
16
F41.01
ICD-10 Finland
Severe panic disorder
8.3
6.4
13
16
S71.1
ICD-10 Finland
Open wound of thigh
5.6
6.3
17
31
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
11.1
6.3
11
10
F11.1
ICD-10 Finland
Mental and behavioural disorders due to use of opioids, harmful use
11.1
6.3
11
10
IAB08
NOMESCO Finland
Consultation concerning a patient who has attempted suicide
11.1
6.3
11
10
SPAT1243
SPAT
Psychiatric/psychological examination
2.9
6.3
36
127
A02BC05
ATC
esomeprazole; systemic
1.6
6.3
223
1615
P02
ICPC
Acute stress reaction
2.6
6.3
44
176
K29.2
ICD-10 Finland
Alcoholic gastritis
18.2
6.3
9
5
S02.65
ICD-10 Finland
Fracture of the symphysis mandipulae
+∞
6.3
6
*
F11.2
ICD-10 Finland
Mental and behavioural disorders due to use of opioids, dependence syndrome
+∞
6.3
6
*
X91.0
ICD-10 Finland
Assault by hanging, strangulation and suffocation by spouse or partner
+∞
6.3
6
*
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.8
6.2
38
142
W01
ICPC
Question of pregnancy
7.1
6.2
14
20
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
3.7
6.2
25
69
B86
ICD-10 Finland
Scabies
3.8
6.2
24
64
A02BC03
ATC
lansoprazole; oral
1.7
6.2
150
985
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.0
6.2
33
113
S70.1
ICD-10 Finland
Contusion of thigh
5.1
6.2
18
36
TNX39
NOMESCO Finland
Other orthopedic bandage, unspecified region
5.1
6.2
18
36
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
7.8
6.1
13
17
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
7.8
6.1
13
17
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.3
6.1
57
264
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.2
6.1
58
274
F13.24
ICD-10 Finland
Addiction relationship caused by sedative and hypnotic active addiction
12.7
6.1
10
8
S02.61
ICD-10 Finland
Fracture of mandible, open
12.7
6.1
10
8
TKC20
NOMESCO Finland
Catheterisation of bladder
2.7
6.1
39
148
M01AB05
ATC
diclofenac; systemic, rectal
1.5
6.1
422
3531
ND1AI
NOMESCO Finland
Cone beam CT of wrist
8.7
6.1
12
14
NH1AD
NOMESCO Finland
Ankle and foot CT
4.2
6.0
21
51
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.1
6.0
64
317
N06AG02
ATC
moclobemide; oral
3.1
6.0
31
104
S21
ICPC
Skin texture symptom/complaint
2.1
6.0
70
358
V19
ICD-10 Finland
Pedal cyclist injured in other and unspecified transport accidents
3.7
6.0
24
66
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3020191) Ethanol [Moles/volume] in Serum or Plasma
80
66
13.37
81.66
2.3
1.7
promille
1.9
1.3
1.59
59
54
(3028707) Methadone [Presence] in Urine by Screen method
141
255
6.51
77.28
7.5
3.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
311
1221
3.55
62.35
3.3
1.9
%
1.7
1.4
8.70
262
1123
(3011288) Drugs identified in Urine by Screen method
164
412
4.76
61.66
10.7
3.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
170
494
4.11
52.31
7.1
2.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
415
2130
3.00
50.22
7.1
6.5
mmol/l
1.2
1.2
2.96
381
1963
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
490
2776
3.01
49.04
6.2
6.5
umol/l
10.3
11.3
1.10
455
2649
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
49
43
12.08
47.76
1.8
1.7
iu/ml
1303713.6
875521.4
—
7
7
(3032080) INR in Blood by Coagulation assay
376
1877
2.91
47.11
7.4
6.5
inr
1.1
1.1
0.08
133
613
(3016879) Cocaine [Presence] in Urine
179
582
3.68
46.48
7.1
2.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
429
2344
2.81
44.53
8.3
7.2
mmol/l
1.2
1.2
3.45
361
2019
(3000764) Benzodiazepines [Presence] in Urine
182
626
3.48
43.09
7.1
2.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
182
632
3.44
42.39
7.1
2.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
182
634
3.43
42.16
7.2
2.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
519
3198
2.81
41.48
6.9
5.0
mmol/l
6.3
6.5
1.12
497
2951
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
341
1718
2.73
40.52
3.7
2.6
u/l
56.3
57.4
0.22
312
1618
(3023368) Bacteria identified in Blood by Culture
278
1284
2.80
38.86
5.2
4.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
305
1508
2.66
36.93
3.1
2.1
u/l
349.1
277.1
0.46
291
1440
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
46
54
8.98
36.44
2.1
1.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
171
626
3.21
36.09
6.4
2.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
619
4374
2.91
34.65
8.4
7.3
u/l
76.8
75.5
0.35
590
4145
(3042517) Benzodiazepines panel - Urine
25
13
19.83
31.94
2.9
2.9
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
365
2109
2.36
30.08
5.8
5.4
g/l
36.1
37.1
2.89
337
1994
(42870588) Differential panel, method unspecified - Blood
346
1976
2.33
29.04
5.1
6.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
173
736
2.73
27.21
2.0
1.8
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
36
45
8.33
27.06
4.1
2.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
325
1854
2.28
26.84
4.1
2.8
ng/l
20.4
44.1
1.35
202
1015
(3042936) Bacteria identified in Isolate by Culture
178
778
2.66
26.47
2.5
2.2
—
—
—
0
0
(4198724)
42
66
6.66
25.86
4.5
2.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
160
672
2.73
25.69
1.9
1.6
nmol/l
1135.0
1160.9
0.13
123
545
(3009508) Creatinine [Moles/volume] in Urine
296
1650
2.27
25.59
5.7
3.4
mmol/l
7.5
8.8
3.36
251
1429
(3017143) Hepatitis C virus Ab [Presence] in Serum
226
1135
2.39
24.82
2.3
1.7
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
509
3549
2.22
24.76
4.7
3.5
e6/l
6039.8
383.6
—
5
41
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
66
164
4.30
24.45
2.3
2.3
ug/l
614.3
318.1
0.46
60
156
(3033658) Prothrombin time (PT) actual/Normal
262
1441
2.22
22.94
5.1
4.0
%
93.4
93.8
0.10
255
1412
(44816559) Phosphatidylethanol [Mass/volume] in Blood
71
196
3.88
22.80
1.6
1.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
740
6231
3.91
22.31
20.4
11.5
mmol/l
139.2
139.6
3.33
725
6080
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
21
16
13.46
22.04
1.1
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
293
1718
2.12
21.53
2.8
2.2
—
—
—
0
0
(3013512) EKG study
239
1296
2.21
21.44
3.5
3.0
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
739
6258
3.75
21.20
20.6
11.6
mmol/l
3.9
3.9
1.01
723
6093
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
239
1304
2.19
21.06
2.7
2.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
403
2674
2.03
21.00
4.5
3.9
—
—
—
0
0
(3019225) pH of Specimen
109
414
2.89
20.94
4.6
4.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
29
38
7.88
20.93
1.7
5.2
umol/l
121.9
176.8
0.46
14
20
(46235355) HIV 1 and 2 tests - Meaningful Use set
325
2002
2.06
20.75
2.7
2.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
346
2182
2.04
20.69
4.1
3.5
u/l
37.4
33.2
1.29
326
2079
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
260
1477
2.13
20.59
2.8
2.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
250
1399
2.15
20.58
3.8
4.0
ph
7.4
7.4
0.01
59
252
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
243
1349
2.16
20.39
2.8
2.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
110
426
2.84
20.37
3.2
4.2
mmol/l
1.6
1.9
0.28
86
337
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
624
4900
2.30
20.25
5.5
3.1
u/l
71.6
43.6
3.72
597
4701
(3006315) Basophils [#/volume] in Blood
441
3051
2.01
20.10
5.8
6.3
e9/l
0.0
0.0
3.25
382
2690
(3012095) Magnesium [Moles/volume] in Serum or Plasma
172
835
2.35
19.94
3.8
3.9
mmol/l
0.8
0.8
1.05
163
793
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
219
1179
2.19
19.78
2.1
2.1
mg/l
2.9
2.8
0.41
190
1028
(3013650) Neutrophils [#/volume] in Blood by Automated count
484
3474
2.01
19.70
8.1
9.4
e9/l
4.5
4.0
3.29
420
3055
(3001604) Monocytes [#/volume] in Blood
438
3041
1.99
19.56
5.7
6.2
e9/l
0.6
0.6
4.79
375
2684
(3013115) Eosinophils [#/volume] in Blood
450
3160
1.98
19.37
6.0
6.7
e9/l
0.2
0.2
0.74
392
2829
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
121
506
2.64
19.27
10.2
10.3
kpa
5.2
5.1
0.31
116
483
(3027801) Oxygen [Partial pressure] in Arterial blood
121
506
2.64
19.27
10.2
10.3
kpa
12.3
12.9
0.59
116
486
(3014111) Lactate [Moles/volume] in Serum or Plasma
108
427
2.77
19.20
7.3
9.3
mmol/l
1.4
1.4
0.05
103
418
(3006504) Eosinophils/100 leukocytes in Blood
416
2857
1.96
18.97
5.8
6.3
%
2.7
2.9
0.80
396
2706
(3021960) Folate [Moles/volume] in Serum or Plasma
193
1006
2.21
18.78
1.5
1.4
nmol/l
18.8
20.1
0.68
172
883
(3019069) Monocytes/100 leukocytes in Blood
416
2875
1.94
18.43
6.0
6.6
%
8.3
8.4
0.51
397
2743
(3003396) Base excess in Arterial blood by calculation
119
505
2.60
18.36
10.3
10.4
mmol/l
0.2
1.1
1.20
97
407
(3022096) Basophils/100 leukocytes in Blood
402
2756
1.93
18.15
5.9
6.5
%
0.7
0.7
0.05
383
2615
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
293
1819
1.97
17.64
2.0
1.7
pmol/l
94.9
96.8
0.25
170
1001
(3019198) Lymphocytes [#/volume] in Blood
444
3176
1.91
17.31
5.7
6.3
e9/l
2.1
2.0
1.94
389
2852
(3002030) Lymphocytes/100 leukocytes in Blood
424
3006
1.88
16.81
5.8
6.2
%
29.0
29.3
0.19
398
2866
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
257
1554
1.97
16.49
2.2
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
116
514
2.47
16.27
1.9
1.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
141
683
2.30
16.18
2.0
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
115
511
2.46
16.02
5.4
2.9
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
149
742
2.24
15.99
2.2
2.3
s
30.0
29.5
0.60
144
727
(3013707) Erythrocyte sedimentation rate by Westergren method
553
4315
1.94
15.83
3.8
3.6
mm/h
11.2
8.7
3.19
505
4062
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
736
6435
3.07
15.58
19.2
10.9
mg/l
22.2
21.9
0.11
629
4900
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
71
250
3.02
15.53
3.2
4.4
mmol/l
24.0
24.1
0.05
65
233
(3023511) Choriogonadotropin [Units/volume] in Urine
62
202
3.25
15.45
1.8
1.3
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
415
2972
1.83
15.45
5.7
6.1
%
56.1
56.3
0.12
392
2837
(3000991) Gas panel - Venous blood
96
409
2.53
14.59
9.0
10.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
49
143
3.59
14.49
2.4
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
113
522
2.36
14.39
1.9
1.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
285
1849
1.85
14.36
3.5
2.9
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
118
561
2.30
14.05
3.3
2.6
u/l
36.4
126.2
0.55
102
487
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
33
75
4.55
13.66
3.0
1.8
—
—
—
0
0
(3009343) pH of Capillary blood
78
310
2.68
13.63
2.6
3.1
ph
7.4
7.4
0.27
15
37
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
78
313
2.66
13.37
2.6
3.1
kpa
5.1
5.2
0.57
73
295
(3012501) Base excess in Blood by calculation
42
118
3.70
13.13
4.0
3.9
mmol/l
2.6
2.7
0.04
30
79
(3026782) Osmolality of Urine
176
1005
1.97
12.93
2.9
2.5
mosm/kgh2o
529.6
570.6
1.16
158
856
(3015377) Calcium [Moles/volume] in Serum or Plasma
254
1634
1.82
12.89
2.8
3.2
mmol/l
2.3
2.4
0.52
219
1480
(3022217) INR in Platelet poor plasma by Coagulation assay
103
479
2.32
12.87
12.7
15.2
inr
1.2
1.2
0.04
18
77
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
165
927
1.99
12.68
4.6
3.3
ng/l
168.1
745.1
2.05
102
603
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
102
479
2.30
12.45
2.7
2.7
g/l
0.2
0.2
1.98
92
450
(3026008) Bacteria identified in Urine by Culture
199
1200
1.88
12.35
3.2
2.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
73
298
2.60
12.08
2.7
3.1
mmol/l
1.4
1.3
0.04
45
213
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
165
948
1.94
11.81
1.6
1.5
pmol/l
455.7
34767458.4
1.22
127
837
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
569
4666
1.78
11.76
4.1
3.6
pmol/l
14.5
14.6
0.06
517
4322
(3025941) Bacteria identified in Stool by Culture
85
379
2.39
11.67
1.3
1.2
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
42
130
3.36
11.37
6.7
6.0
umol/l
364.5
362.5
0.03
34
121
(3021879) Hepatitis B virus core Ab [Presence] in Serum
136
740
2.01
11.36
2.0
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
368
2714
1.67
11.01
12.3
8.6
e9/l
0.0
0.0
0.10
291
2236
(3030467) Casts [#/volume] in Urine by Automated count
221
1424
1.77
10.85
3.4
2.8
e6/l
0.6
0.3
0.35
170
1049
(3019060) Gas panel - Arterial blood
68
285
2.52
10.66
8.3
6.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
44
146
3.13
10.66
1.1
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
33
91
3.74
10.62
3.0
2.3
%
16.5
16.9
0.15
15
42
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
135
750
1.96
10.59
2.7
2.8
mmol/l
2.4
2.4
0.03
109
656
(3022313) Gas panel - Capillary blood
58
229
2.65
10.26
2.4
3.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
112
590
2.05
10.18
3.6
3.6
%
29.0
30.2
0.52
85
433
(1616796) Gas panel - Central venous blood
36
109
3.41
10.10
3.8
3.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
494
3977
1.64
10.08
4.6
3.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
270
1874
1.67
9.97
3.9
3.3
e6/l
49.1
80.3
0.49
195
1291
(3019150) Specific gravity of Urine by Refractometry
199
1272
1.75
9.94
4.1
3.0
kg/l
1.0
1.0
0.27
25
161
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
62
258
2.52
9.87
15.0
13.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
217
1425
1.72
9.83
3.4
2.7
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
123
679
1.96
9.79
2.4
3.1
umol/l
7.3
7.6
0.05
93
595
(3000850) Epithelial cells [#/volume] in Urine
172
1059
1.80
9.74
2.8
2.4
e6/l
16.0
6.4
0.46
156
923
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
75
345
2.30
9.58
3.9
4.0
mmol/l
1.2
1.2
1.77
65
308
(3002582) Erythrocytes [#/volume] in Urine
232
1563
1.69
9.52
3.4
2.8
e6/l
20.8
92.8
1.03
184
1186
(3003181) Sodium [Moles/volume] in Urine
23
53
4.44
9.38
1.5
1.4
mmol/l
49.8
65.4
0.68
16
47
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
647
5646
1.80
9.25
5.0
4.2
mu/l
1.9
2.2
0.52
598
5317
(1761868) Lipid panel - Serum or Plasma
196
2826
0.59
9.05
2.6
2.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
36
117
3.18
9.04
3.0
4.1
u/ml
0.3
0.3
0.01
16
61
(3007463) Buprenorphine [Presence] in Urine
13
7
18.85
8.95
11.3
5.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
38
956
0.37
8.92
1.4
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
202
1336
1.69
8.78
1.9
1.8
mg/l
1.1
1.0
0.23
138
979
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
669
5936
1.82
8.53
15.4
9.3
ml/min/173m2
95.8
93.2
2.26
569
4807
(3000570) Elastase.pancreatic [Mass/mass] in Stool
39
138
2.92
8.49
1.5
1.6
ug/g
257.3
297.8
0.43
21
79
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
54
227
2.48
8.43
1.4
1.5
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
12
16
7.60
8.43
4.8
2.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
158
997
1.73
8.10
2.7
3.1
ng/l
1123.4
830.3
0.43
114
802
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
78
391
2.10
8.07
3.0
2.5
u/l
7980.8
4010.3
0.22
23
168
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
108
609
1.90
8.02
2.4
2.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
94
507
1.97
7.96
4.3
3.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
620
5439
1.65
7.59
4.8
4.5
mmol/mol
38.3
38.5
0.25
561
5187
(40758558) Short blood count panel - Blood
209
1445
1.61
7.48
6.7
6.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
33
115
2.95
7.40
1.3
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
40
155
2.66
7.38
3.1
2.0
ug/l
3.2
2.5
0.10
35
144
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
69
342
2.11
7.35
1.6
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
22
656
0.32
7.28
1.2
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
744
6913
2.28
7.28
12.5
8.8
u/l
33.3
30.4
1.70
732
6738
(3020891) Body temperature
43
176
2.53
7.12
3.6
4.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
43
177
2.51
7.04
2.0
1.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
30
102
3.02
7.03
2.5
4.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
57
267
2.22
7.00
2.1
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
36
137
2.71
6.89
1.2
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
28
94
3.05
6.71
2.2
1.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
78
424
1.93
6.46
3.1
4.3
%
0.8
0.5
0.33
20
100
(3011397) Hemoglobin [Presence] in Urine by Test strip
176
1206
1.59
6.44
2.9
3.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
62
1143
0.50
6.42
1.2
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
123
771
1.70
6.39
2.6
2.0
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
35
137
2.63
6.36
2.5
2.4
—
4.7
—
0
6
(3000494) Fungus identified in Specimen by Culture
112
685
1.74
6.35
1.7
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
67
350
2.00
6.22
1.9
2.1
ug/l
7.1
9.8
0.36
60
321
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
45
203
2.29
6.06
1.5
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
360
2893
1.45
6.05
3.5
2.9
estimate
0.0
0.0
0.49
85
528
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
28
101
2.84
5.95
1.1
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
28
101
2.84
5.95
1.1
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
356
2868
1.44
5.84
3.5
2.9
estimate
0.0
0.0
0.50
83
544
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
39
168
2.39
5.83
1.4
1.7
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
120
768
1.66
5.75
2.5
2.4
umol/l
12.9
14.8
2.07
112
719
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
122
787
1.65
5.67
2.8
2.6
e6/l
3.3
2.2
0.63
58
411
(3037522) Nuclear Ab [Titer] in Serum
133
878
1.62
5.63
1.3
1.4
titre
419.1
439.5
0.06
23
167
(3021601) Nitrite [Presence] in Urine by Test strip
355
2873
1.43
5.61
4.7
4.1
estimate
0.0
0.0
0.50
90
570
(3019832) Treponema pallidum Ab [Presence] in Serum
163
1133
1.55
5.54
2.1
1.8
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
62
331
1.95
5.43
1.4
1.4
miu/ml
182.5
245.2
0.52
20
162
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
216
1600
1.48
5.43
1.3
1.3
u/ml
0.9
1.9
1.03
52
469
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
649
5896
1.56
5.42
4.3
3.5
mmol/l
5.9
5.8
1.04
588
5522
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
126
829
1.62
5.40
2.6
2.5
e6/l
0.5
1.0
1.86
61
453
(3017181) Myelocytes/100 leukocytes in Blood
79
458
1.81
5.37
3.2
4.5
%
0.7
0.9
0.24
24
137
(3004789) Transferrin [Mass/volume] in Serum or Plasma
112
718
1.65
5.32
2.5
2.4
g/l
2.4
2.4
0.29
103
668
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
288
2262
1.43
5.30
2.4
2.3
nmol/l
66.0
72.2
2.85
263
2104
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
93
568
1.72
5.29
4.6
5.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
105
663
1.67
5.29
2.5
2.5
%
22.8
25.5
0.91
84
580
(3029937) Albumin [Presence] in Urine by Test strip
203
1492
1.49
5.29
3.6
3.1
estimate
0.0
0.0
1.08
85
551
(3021440) Promyelocytes/100 leukocytes in Blood
75
432
1.81
5.21
3.3
4.5
%
0.0
0.1
0.72
23
128
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
55
286
1.99
5.20
1.4
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
28
109
2.63
5.18
1.5
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
58
309
1.95
5.12
1.7
3.2
e9/l
63.2
73.1
1.65
43
224
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
227
1725
1.44
4.93
1.8
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
338
2760
1.39
4.87
2.8
2.7
ug/l
113.1
113.3
0.01
304
2612
(40761511) CBC panel - Blood by Automated count
729
6861
1.80
4.77
17.2
9.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
111
732
1.60
4.71
1.3
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
190
1423
1.44
4.41
1.4
1.4
g/l
2.8
2.3
1.76
104
956
(36660697) Celiac disease serology panel - Serum
88
563
1.63
4.22
1.2
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
20
73
2.78
4.21
1.2
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
59
338
1.81
4.21
1.8
1.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
24
97
2.52
4.16
2.8
2.6
g/l
131.8
135.1
0.24
19
69
(3021901) Oxygen saturation in Capillary blood
19
68
2.84
4.14
3.2
2.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
88
567
1.62
4.11
1.6
2.0
nmol/l
366.7
366.1
0.01
82
537
(3044889) 12 lead EKG panel
454
3966
1.34
3.94
3.6
3.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
71
443
1.66
3.77
1.7
3.2
%
1.6
1.7
0.32
58
406
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
22
90
2.49
3.74
1.5
1.8
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
31
148
2.14
3.73
3.5
3.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
67
414
1.68
3.69
3.1
4.6
%
0.0
0.2
1.27
19
110
(3042631) Mycobacterium sp identified in Specimen
16
56
2.90
3.64
1.9
3.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
26
117
2.26
3.61
2.8
4.0
%
57.8
56.4
0.26
26
117
(3037121) Protein [Mass/volume] in Urine
35
179
2.00
3.53
3.5
3.7
g/l
0.3
0.2
0.23
17
93
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
41
3.21
3.50
2.3
2.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
129
937
1.45
3.49
2.1
2.7
ug/g
133.0
121.2
0.16
100
767
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
19
75
2.57
3.48
1.2
1.2
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
10
7.05
3.37
1.0
1.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
130
953
1.44
3.34
1.3
1.2
u/ml
4.5
8.5
0.63
44
402
(3048929) Epstein Barr virus Ab [Presence] in Serum
56
345
1.67
3.15
1.2
1.2
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
13
44
2.99
3.14
1.2
1.2
—
60.5
—
0
6
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
24
112
2.18
3.09
1.3
1.5
u/l
22.5
20.4
0.12
19
95
(3003327) Ova and parasites identified in Stool by Light microscopy
42
240
1.79
3.08
1.8
1.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
243
2001
1.31
2.99
1.5
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
38
213
1.82
2.97
2.2
2.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
34
184
1.89
2.96
1.1
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
24
115
2.12
2.91
2.8
3.9
e9/l
5.2
4.3
0.67
24
115
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
25
122
2.08
2.90
1.1
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
165
1290
1.35
2.89
3.3
3.5
mg/l
743.8
266.5
0.46
102
873
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
50
308
1.67
2.84
3.9
4.5
ng/l
111.2
80.4
0.99
45
290
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
272
2289
1.29
2.81
3.6
2.9
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
6
10
6.04
2.70
1.2
1.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
17
73
2.36
2.66
1.0
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
7
15
4.70
2.60
1.1
1.5
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
48
301
1.63
2.57
3.7
2.6
ng/l
136.8
106.2
0.39
43
264
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
13
50
2.63
2.54
1.2
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
170
1360
1.32
2.54
4.2
4.2
mg/mmol
13.8
10.4
0.32
103
909
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
10
33
3.06
2.53
1.0
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
11
39
2.85
2.48
1.1
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
56
368
1.56
2.48
2.7
2.9
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
188
1530
1.30
2.48
1.7
1.7
mmol/l
1.7
1.5
1.35
147
1347
(3040151) Glucose [Moles/volume] in Capillary blood
12
45
2.69
2.46
2.8
8.3
mmol/l
6.1
7.3
0.80
12
38
(3011648) Oxygen content in Venous blood
12
45
2.69
2.46
1.2
6.1
%
11.4
12.1
0.17
12
45
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
14
57
2.48
2.46
1.1
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
14
57
2.48
2.46
1.1
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
27
145
1.89
2.44
1.1
1.4
mmol/l
3.7
3.6
0.11
22
138
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
132
1024
1.35
2.43
1.4
1.3
iu/ml
30.2
22.4
0.29
37
319
(3024731) MCV [Entitic volume]
766
7462
1.84
2.40
26.6
15.6
fl
91.1
89.9
10.91
760
7387
(3035941) MCH [Entitic mass]
766
7462
1.84
2.40
26.6
15.5
pg
30.6
30.2
6.92
760
7386
(3026361) Erythrocytes [#/volume] in Blood
766
7463
1.84
2.38
26.7
15.6
e12/l
4.5
4.7
11.64
751
7302
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
21
104
2.05
2.38
1.3
1.8
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
765
7451
1.81
2.37
26.8
15.6
e9/l
257.3
253.1
1.01
751
7300
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
8
22
3.66
2.37
1.1
1.8
umol/l
14.4
17.2
—
8
22
(40760892) CBC W Ordered Manual Differential panel - Blood
188
1539
1.29
2.36
4.3
4.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
15
65
2.33
2.32
1.3
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
28
3.24
2.31
1.0
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
28
3.24
2.31
1.0
1.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
766
7468
1.81
2.30
26.9
15.7
g/l
137.7
140.7
5.75
759
7389
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
25
134
1.89
2.29
2.1
1.9
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
25
134
1.89
2.29
2.1
1.9
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
16
72
2.25
2.29
1.0
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
16
72
2.25
2.29
1.0
1.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
766
7469
1.81
2.28
26.8
15.6
e9/l
7.4
6.6
19.03
749
7304
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
11
41
2.71
2.28
9.5
9.6
u/ml
755.8
181.4
—
6
18
(3005719) IgG [Mass/volume] in Serum or Plasma
70
492
1.46
2.28
1.6
2.3
g/l
11.7
10.3
1.15
64
449
(3041806) Other cells [#/volume] in Blood by Manual count
0
59
0.00
2.25
0.0
1.7
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
16
73
2.22
2.22
1.0
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
16
73
2.22
2.22
1.0
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
16
73
2.22
2.22
1.0
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
18
88
2.07
2.12
1.4
1.6
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
10
37
2.72
2.11
1.2
1.2
u/l
443.7
793.4
—
10
32
(4010399)
56
383
1.50
2.10
1.3
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
11
43
2.58
2.10
1.4
1.6
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
14
62
2.28
2.08
1.1
1.1
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
6
15
4.02
2.04
1.5
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
85
636
1.38
1.99
1.2
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
10
39
2.58
1.92
1.0
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
22
3.20
1.88
1.3
1.8
—
—
—
0
0
(3002256) Pathology report gross observation
88
672
1.35
1.82
1.2
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
10
220
0.45
1.81
1.2
1.5
—
—
—
0
0
(4034850)
30
184
1.66
1.81
10.4
7.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
34
216
1.60
1.79
1.5
1.9
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
12
54
2.24
1.74
1.0
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
7
24
2.93
1.72
1.7
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
7
24
2.93
1.72
1.1
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
24
141
1.72
1.70
1.4
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
13
62
2.12
1.66
1.2
1.8
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
8
31
2.60
1.66
1.0
1.3
nmol/l
139.0
151.2
—
8
31
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
87
1107
0.76
1.65
2.6
2.3
ug/l
0.6
0.7
0.50
57
556
(3041096) Erythrocytes [Presence] in Urine by Automated
203
1746
1.22
1.63
3.4
2.5
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
17
92
1.87
1.57
1.9
2.5
mg/l
21.8
31.2
1.64
17
73
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
24
145
1.68
1.55
2.8
3.0
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
51
366
1.42
1.55
1.1
1.1
—
168.6
—
0
7
(3026493) Urate [Moles/volume] in Serum or Plasma
169
1434
1.23
1.55
2.4
2.5
umol/l
2460.4
4423.3
0.38
143
1309
(3021387) Prolactin [Units/volume] in Serum or Plasma
53
384
1.41
1.53
1.5
1.6
mu/l
285.2
275.2
0.10
46
347
(3006270) Folate [Moles/volume] in Blood
0
42
0.00
1.53
0.0
1.1
—
417.9
—
0
37
(3001556) Androgen free Index in Serum or Plasma
5
15
3.35
1.52
1.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
20
117
1.73
1.46
1.4
1.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
14
73
1.93
1.44
1.4
1.5
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
16
3.14
1.44
1.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
16
3.14
1.44
1.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
16
3.14
1.44
1.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
16
3.14
1.44
1.0
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
22
2.74
1.43
2.3
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
10
46
2.19
1.40
1.3
1.8
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
24
151
1.61
1.36
1.4
1.4
e6/l
10.0
15.5
0.25
16
119
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
9
42
2.16
1.34
1.6
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
91
1117
0.79
1.32
1.6
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
30
201
1.51
1.31
1.2
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
9
43
2.11
1.30
2.3
1.9
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
35
243
1.46
1.30
1.7
1.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
13
69
1.90
1.29
1.5
2.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
30
202
1.50
1.29
1.2
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
10
48
2.10
1.28
1.2
1.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
14
77
1.83
1.26
1.3
1.6
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
16
92
1.75
1.25
2.0
2.5
mg/l
24.5
108.0
0.64
16
73
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
126
1483
0.82
1.24
3.4
3.0
%
18.5
21.4
1.19
43
488
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
19
2.64
1.21
1.6
3.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
19
2.64
1.21
1.6
3.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
30
205
1.48
1.21
1.2
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
54
411
1.34
1.20
1.1
1.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
95
780
1.25
1.20
2.5
2.3
nmol/l
12.7
14.1
1.10
84
726
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
16
94
1.72
1.18
2.5
2.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
27
391
0.68
1.17
2.4
1.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
130
0.46
1.16
1.3
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
72
1.82
1.15
1.5
2.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
36
0.00
1.14
0.0
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
11
58
1.91
1.12
1.1
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
35
479
0.72
1.12
1.8
1.6
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
21
2.39
1.09
1.2
1.8
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
11
59
1.88
1.07
1.1
1.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
56
438
1.30
1.06
1.2
1.3
u/ml
530.3
274.5
0.33
51
402
(1002224) Polysomnography panel
28
393
0.70
1.05
1.1
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
45
343
1.33
1.02
1.3
1.5
u/l
7.7
7.3
0.09
33
288
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
53
1.90
1.01
1.0
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
7
35
2.01
1.00
1.6
3.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
14
84
1.68
0.98
1.3
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
29
0.00
0.98
0.0
2.6
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
32
0.00
0.95
0.0
1.0
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
9
51
1.77
0.94
1.7
2.3
mmol/l
3.9
4.0
—
9
51
(3035285) Chloride [Moles/volume] in Venous blood
9
51
1.77
0.94
1.7
2.3
mmol/l
107.0
105.3
—
9
51
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
27
192
1.42
0.93
1.4
2.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
54
431
1.27
0.90
2.0
2.5
e9/l
4.3
4.1
0.25
41
377
(3044927) Protein electrophoresis panel - Urine
6
29
2.08
0.89
1.2
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
29
2.08
0.89
1.0
1.0
—
—
—
0
0
(4094501)
9
153
0.58
0.89
1.3
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
565
5438
1.14
0.89
3.8
3.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
13
79
1.66
0.88
1.7
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
46
361
1.29
0.88
1.1
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
43
1.87
0.87
1.4
2.5
pg
31.5
33.4
—
8
43
(3004716) Salmonella sp identified in Stool by Organism specific culture
54
433
1.27
0.87
1.3
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
30
2.01
0.87
1.7
1.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
28
204
1.39
0.86
1.3
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
16
239
0.66
0.86
1.6
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
31
1.94
0.84
1.7
1.7
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
8
137
0.58
0.84
1.4
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
48
382
1.27
0.83
3.1
3.9
pmol/l
4.4
4.8
1.25
39
350
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
18
121
1.50
0.83
1.3
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
16
237
0.67
0.83
1.6
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
11
65
1.70
0.82
1.8
1.5
—
—
—
0
0
(4035726)
48
384
1.27
0.80
1.3
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
24
0.00
0.79
0.0
1.7
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
33
1.82
0.79
1.7
1.8
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
23
313
0.73
0.76
1.4
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
17
244
0.69
0.76
1.6
1.5
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
5
24
2.09
0.74
1.2
1.0
—
11.0
—
0
6
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
134
0.59
0.74
1.0
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
5
25
2.01
0.72
2.0
1.6
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
25
2.01
0.72
2.2
2.6
ug/l
110.0
67.7
—
5
25
(3023430) Cat dander IgE Ab [Units/volume] in Serum
19
134
1.43
0.72
1.1
1.1
u/ml
14.1
5.1
—
9
58
(4146454)
7
40
1.76
0.71
1.7
2.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
26
1.93
0.70
1.0
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
26
1.93
0.70
1.0
1.2
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
7
41
1.71
0.70
1.9
3.4
—
28.9
—
0
7
(3032773) Endomysium IgG Ab [Titer] in Serum
10
61
1.65
0.68
1.0
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
27
1.86
0.68
1.2
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
9
59
1.53
0.68
1.2
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
57
478
1.21
0.65
1.2
1.2
iu/ml
67.4
161.6
1.80
18
203
(44790048)
11
70
1.58
0.65
1.5
2.0
—
—
—
0
0
(44806118)
11
70
1.58
0.65
1.5
2.0
—
—
—
0
0
(44790047)
11
70
1.58
0.65
1.5
2.0
—
—
—
0
0
(44790049)
11
70
1.58
0.65
1.5
2.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
11
70
1.58
0.65
1.0
1.2
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
10
62
1.62
0.65
1.8
2.2
—
45.1
—
0
10
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
20
146
1.38
0.64
1.5
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
22
290
0.75
0.62
1.5
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
49
1.64
0.62
3.3
1.9
—
—
—
0
0
(4281824)
5
30
1.67
0.61
1.4
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
30
1.67
0.61
1.4
1.7
—
—
—
0
0
(40768441) Liver Pathology biopsy report
8
50
1.61
0.61
1.0
1.8
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
22
289
0.75
0.61
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
22
289
0.75
0.61
1.5
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
579
5630
1.11
0.61
22.5
13.3
%
13.6
13.4
3.53
565
5527
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
0
21
0.00
0.60
0.0
2.4
—
121.1
—
0
9
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
80
1.51
0.60
1.5
1.9
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
22
288
0.76
0.60
1.5
1.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
11
72
1.54
0.59
1.2
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
11
72
1.54
0.59
1.5
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
55
1.46
0.56
3.3
1.8
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
18
133
1.36
0.55
1.9
2.2
umol/l
8.1
6.4
—
10
99
(4062490)
9
61
1.48
0.54
1.4
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
32
259
1.25
0.53
1.5
1.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
25
196
1.28
0.53
1.2
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
62
1.46
0.53
3.1
2.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
106
955
1.13
0.52
1.6
1.5
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
40
1.50
0.51
1.2
1.1
iu/ml
101.6
196.5
—
6
40
(3000093) Morphology [Interpretation] in Blood Narrative
6
41
1.47
0.50
1.3
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
36
298
1.22
0.50
2.3
2.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
67
1.50
0.50
1.8
1.9
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
166
0.72
0.48
3.2
1.7
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
19
146
1.31
0.47
5.6
2.1
nmol/l
1.0
0.9
0.50
19
128
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
48
1.46
0.47
1.1
2.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
16
120
1.34
0.46
2.0
1.9
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
44
376
1.18
0.45
3.5
4.8
ug/l
5.0
19.5
0.67
34
302
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
10
69
1.46
0.44
1.0
1.1
mg/l
297.6
277.6
—
10
62
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
51
1.38
0.44
1.9
2.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
14
104
1.35
0.43
1.1
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
29
349
0.82
0.43
1.3
1.4
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
5
32
1.57
0.42
1.2
1.6
nmol/l
2.2
2.1
—
5
27
(40768446) Kidney Pathology biopsy report
5
32
1.57
0.42
2.4
1.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
8
57
1.41
0.42
1.0
3.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
10
70
1.43
0.42
2.3
2.6
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
16
0.00
0.41
0.0
1.4
—
1.2
—
0
16
(3030981) Hyaline casts [#/volume] in Urine by Automated count
30
250
1.21
0.41
1.8
2.4
e6/l
0.4
0.1
0.38
30
243
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
11
79
1.40
0.41
1.1
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
17
0.00
0.40
0.0
1.1
—
0.7
—
0
10
(4024509)
5
34
1.47
0.40
1.2
1.4
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
5
34
1.47
0.40
4.2
4.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.4
—
132.8
—
0
14
(3023323) Follitropin [Units/volume] in Serum or Plasma
44
382
1.16
0.39
1.3
1.4
iu/l
19.8
20.1
0.02
31
323
(3024891) Influenza virus A+B Ag [Presence] in Specimen
27
224
1.21
0.39
1.1
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
36
1.39
0.38
1.0
1.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
24
197
1.23
0.38
1.3
1.2
u/ml
189.8
238.3
0.94
17
122
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
23
188
1.23
0.38
1.7
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
13
98
1.33
0.37
1.2
1.9
—
—
—
0
0
(3000492) Spirometry study
81
736
1.11
0.37
1.4
1.4
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
10
135
0.74
0.36
1.2
1.1
—
7.9
—
0
13
(3014148) Varicella zoster virus Ab [Titer] in Serum
9
124
0.72
0.35
1.0
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
229
2185
1.07
0.35
1.8
1.9
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
6
44
1.37
0.34
3.0
2.7
mg/l
110.3
17.9
—
6
32
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
24
200
1.21
0.34
1.1
1.1
u/ml
1.2
2.7
0.61
11
83
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
45
1.34
0.34
1.3
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
16
198
0.80
0.32
1.6
2.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
15
119
1.27
0.32
1.5
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
15
119
1.27
0.32
1.3
1.3
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
26
221
1.18
0.31
1.5
2.1
u/ml
85.5
42.6
0.28
26
210
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
46
410
1.13
0.30
1.3
1.3
—
38.0
—
0
22
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
15
120
1.25
0.30
1.3
1.2
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
28
243
1.16
0.27
1.1
1.5
—
8.5
—
0
14
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
10
127
0.78
0.25
1.4
1.2
u/ml
1.4
4.0
—
5
40
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
75
1.20
0.25
1.1
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
646
6388
1.06
0.25
4.2
3.9
mmol/l
2.8
2.9
1.39
588
6059
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
77
1.17
0.24
1.1
1.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
24
275
0.87
0.23
1.3
2.1
u/l
43.2
39.4
0.49
17
253
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
24
209
1.15
0.23
1.5
1.3
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
18
153
1.18
0.22
1.1
1.1
u/ml
12.0
3.9
—
10
63
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
40
1.25
0.22
1.0
1.3
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
5
40
1.25
0.22
1.0
1.5
u/l
7.2
8.0
—
5
35
(40768795) Lymph node Pathology biopsy report
5
40
1.25
0.22
1.2
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.3
—
1.8
—
0
11
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
10
0.00
0.21
0.0
3.6
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
0
12
0.00
0.21
0.0
3.3
—
3.0
—
0
12
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
13
0.00
0.21
0.0
1.0
—
6.7
—
0
13
(3026250) Tacrolimus [Mass/volume] in Blood
6
48
1.25
0.20
42.3
33.4
ug/l
7.9
7.8
—
6
41
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
14
0.00
0.20
0.0
1.6
—
1.2
—
0
14
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
49
1.23
0.20
8.7
4.7
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
20
174
1.15
0.20
1.1
1.1
u/ml
4.0
3.6
—
9
46
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
50
1.20
0.19
3.3
3.6
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
10
81
1.24
0.19
1.0
1.4
nmol/l
0.6
0.6
—
10
75
(3045683) HLA typing for celiac disease panel - Blood or Tissue
6
53
1.13
0.18
1.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
61
1.15
0.17
1.3
1.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
604
6098
0.96
0.17
3.6
3.4
mmol/l
1.5
1.3
5.14
546
5797
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
627
6325
0.96
0.17
3.9
3.6
mmol/l
1.3
1.4
3.75
572
6020
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
10
82
1.22
0.17
1.1
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
73
1.10
0.15
1.0
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
8
73
1.10
0.15
1.3
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9
80
1.13
0.15
1.0
1.4
—
—
—
0
0
(4268621)
9
83
1.09
0.14
2.8
2.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
182
1870
0.97
0.14
3.3
3.3
ug/l
1.6
1.5
0.13
155
1730
(3014051) Protein [Presence] in Urine by Test strip
8
96
0.83
0.13
1.1
1.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
99
0.81
0.13
1.8
3.5
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
10
117
0.85
0.13
3.8
3.9
—
3034.2
—
0
9
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
11
127
0.86
0.12
1.2
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
10
116
0.86
0.12
4.1
2.5
ug/min
215.2
159.5
—
5
72
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
19
172
1.11
0.11
1.9
1.9
iu/l
3.6
5.5
—
6
61
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
115
1.13
0.10
1.2
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
51
534
0.95
0.10
1.3
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
79
763
1.04
0.09
1.9
1.8
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
5
48
1.04
0.09
3.0
2.7
e9/l
0.3
0.2
—
5
40
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
21
194
1.08
0.09
1.2
1.4
—
—
—
0
0
(4027681)
6
55
1.09
0.09
2.5
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
22
204
1.08
0.08
1.2
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
10
113
0.88
0.08
2.4
2.5
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
5
61
0.82
0.08
1.0
1.2
—
227.0
—
0
10
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
8
77
1.04
0.07
1.1
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
25
235
1.07
0.07
1.4
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
93
0.86
0.06
1.0
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
20
187
1.07
0.06
1.5
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
637
6346
1.02
0.06
3.9
3.7
mmol/l
4.7
4.7
1.31
584
6053
(3009542) Hematocrit [Volume Fraction] of Blood
644
6463
0.98
0.06
18.9
11.5
%
40.5
41.5
2.23
459
5392
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
11
121
0.91
0.06
1.2
1.1
%
122.2
113.0
0.55
11
113
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
24
229
1.05
0.04
1.6
1.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
14
131
1.07
0.03
2.4
2.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
43
419
1.03
0.03
2.3
2.2
ml/min/173m2
73.4
78.2
0.25
15
169
(3025130) Human papilloma virus identified in Specimen
11
102
1.08
0.03
1.5
1.8
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
11
102
1.08
0.03
1.1
1.4
pmol/l
32.3
77.6
—
5
30
(4306422)
13
123
1.06
0.01
1.2
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
35
344
1.02
0.00
1.0
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
10
105
0.95
0.00
1.0
1.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
17
175
0.97
0.00
1.1
1.1
u/ml
1.2
1.7
—
6
77
(3003888) Timothy IgE Ab [Units/volume] in Serum
18
184
0.98
0.00
1.1
1.1
u/ml
4.0
7.6
—
9
107
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
12
122
0.98
0.00
1.3
1.2
u/ml
3.8
4.0
—
6
55
(3003740) Influenza virus B Ag [Presence] in Specimen
19
192
0.99
0.00
1.5
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
19
191
0.99
0.00
1.5
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
70
1.00
0.00
1.0
1.1
—
—
—
0
0
(4015189)
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
70
1.00
0.00
1.0
1.4
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
16.8
—
0
7
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
0
5
0.00
0.00
0.0
4.8
—
10.1
—
0
5
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
64
0.94
0.00
2.0
2.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
52
0.96
0.00
1.4
1.8
g/l
1.2
1.0
—
5
52
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
187.3
—
0
6
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
50
1.00
0.00
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
51
0.98
0.00
1.2
1.2
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
50
1.00
0.00
1.2
1.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
5.6
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
57.5
—
0
6
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
6
59
1.02
0.00
1.3
1.4
—
72.1
—
0
7
(3022475) Manganese [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
50
1.00
0.00
1.2
1.2
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
5
52
0.96
0.00
1.0
1.0
u/ml
—
7.4
—
0
11
(3003721) Smooth muscle Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.4
—
1.3
—
0
7
(3041672) Baker's yeast Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
5
55
0.91
0.00
1.0
1.0
—
0.3
—
0
20
(3039744) RNA polymerase III Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.8
—
2.2
—
0
5
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
97
0.93
0.00
6.0
3.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
5
54
0.93
0.00
1.6
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
6
63
0.95
0.00
1.5
1.4
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
14.1
—
0
6
(3026726) Creatinine [Moles/volume] in Specimen
0
5
0.00
0.00
0.0
4.0
—
200.6
—
0
5
(44806420)
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
51
0.98
0.00
1.2
1.2
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
10
100
1.00
0.00
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
51
0.98
0.00
1.2
1.2
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
5
51
0.98
0.00
3.0
2.6
e6/l
569.2
497.7
—
5
41
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
1.6
—
0
6
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
60
1.00
0.00
4.2
2.4
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: VWXY20_ASSAU_UNSPE_MEANS – Assault by unspecified means
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).